<code id='60C0F7EC91'></code><style id='60C0F7EC91'></style>
    • <acronym id='60C0F7EC91'></acronym>
      <center id='60C0F7EC91'><center id='60C0F7EC91'><tfoot id='60C0F7EC91'></tfoot></center><abbr id='60C0F7EC91'><dir id='60C0F7EC91'><tfoot id='60C0F7EC91'></tfoot><noframes id='60C0F7EC91'>

    • <optgroup id='60C0F7EC91'><strike id='60C0F7EC91'><sup id='60C0F7EC91'></sup></strike><code id='60C0F7EC91'></code></optgroup>
        1. <b id='60C0F7EC91'><label id='60C0F7EC91'><select id='60C0F7EC91'><dt id='60C0F7EC91'><span id='60C0F7EC91'></span></dt></select></label></b><u id='60C0F7EC91'></u>
          <i id='60C0F7EC91'><strike id='60C0F7EC91'><tt id='60C0F7EC91'><pre id='60C0F7EC91'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:23
          Ron Wyden (left), Mike Crapo (right) -- health policy coverage from STAT
          Draft legislation authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers. Pete Marovich-Pool/Getty Images

          WASHINGTON — A key Senate health care panel has developed a plan to tackle reforms to middlemen in the pharmacy drug payment system, according to bill text obtained by STAT.

          The draft legislation, authored by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho), includes several measures to regulate how pharmacy benefit managers are paid by health plans to negotiate with drugmakers.

          advertisement

          The most significant measure is a bill from Sens. Bob Menendez (D-N.J.) and Marsha Blackburn (R-Tenn.) that would prohibit PBMs from getting any income outside of service fees, and prohibits those service fees from being related to drugs’ list prices.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          The high cost of giving birth even with insurance
          The high cost of giving birth even with insurance

          AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

          read more
          First medicine developed to treat MASH expected to be approved soon
          First medicine developed to treat MASH expected to be approved soon

          MadrigalCEOBillSiboldsaysthecompanyis"interestedinthepatientswhoaremostinneed."MadrigalPharmaceutica

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          UnitedHealth quietly bought dozens of outpatient centers

          ChristineKao/STATUnitedHealthGroupquietlyacquireddozensofoutpatientfacilitiesin2023,withaparticularf